• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人群中心脏起搏器植入的发病率和患病率趋势。

Trends in the incidence and prevalence of cardiac pacemaker insertions in an ageing population.

作者信息

Bradshaw Pamela J, Stobie Paul, Knuiman Matthew W, Briffa Thomas G, Hobbs Michael S T

机构信息

School of Population Health, The University of Western Australia , Perth, Western Australia , Australia.

Department of Cardiovascular Medicine , Sir Charles Gairdner Hospital, Perth, Western Australia , Australia.

出版信息

Open Heart. 2014 Dec 10;1(1):e000177. doi: 10.1136/openhrt-2014-000177. eCollection 2014.

DOI:10.1136/openhrt-2014-000177
PMID:25512875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4265147/
Abstract

OBJECTIVES

To determine contemporary population estimates of the prevalence of cardiac permanent pacemaker (PPM) insertions.

METHODS

A population-based observational study using linked hospital morbidity and death registry data from Western Australia (WA) to identify all incident cases of PPM insertion for adults aged 18 years or older. Prevalence rates were calculated by age and sex for the years 1995-2009 for the WA population.

RESULTS

There were 9782 PPMs inserted during 1995-2009. Prevalence rose across the study period, exceeding 1 in 50 among people aged 75 or older from 2005. This was underpinned by incidence rates which rose with age, being highest in those 85 years or older; over 500/100 000 for men throughout, and over 200/100 000 for women. Rates for patients over 75 were more than double the rates for those aged 65-74 years. Women were around 40% of cases overall. The use of dual-chamber and triple-chamber pacing increased across the study period. A cardiac resynchronisation defibrillator was implanted for 58% of patients treated with cardiac resynchronisation therapy.

CONCLUSIONS

Rates of insertion and prevalence of PPM continue to rise with the ageing population in WA. As equilibrium has probably not been reached, the demand for pacing services in similarly well-developed economies is likely to continue to grow.

摘要

目的

确定当代人群中心脏永久性起搏器(PPM)植入率的估计值。

方法

一项基于人群的观察性研究,利用西澳大利亚州(WA)的医院发病率和死亡登记数据链接,识别所有18岁及以上成年人PPM植入的新发病例。计算了1995 - 2009年WA人群按年龄和性别的患病率。

结果

1995 - 2009年期间共植入9782台PPM。在整个研究期间患病率呈上升趋势,从2005年起,75岁及以上人群中患病率超过五十分之一。这是由发病率随年龄增长而上升所支撑的,85岁及以上人群发病率最高;男性总体发病率超过500/10万,女性超过200/10万。75岁以上患者的发病率是65 - 74岁患者的两倍多。总体病例中女性约占40%。在整个研究期间,双腔和三腔起搏的使用有所增加。接受心脏再同步治疗的患者中有58%植入了心脏再同步除颤器。

结论

在WA,随着人口老龄化,PPM的植入率和患病率持续上升。由于可能尚未达到平衡,在类似发达经济体中,起搏服务的需求可能会继续增长。

相似文献

1
Trends in the incidence and prevalence of cardiac pacemaker insertions in an ageing population.老年人群中心脏起搏器植入的发病率和患病率趋势。
Open Heart. 2014 Dec 10;1(1):e000177. doi: 10.1136/openhrt-2014-000177. eCollection 2014.
2
Using quality indicators to compare outcomes of permanent cardiac pacemaker implantation among publicly and privately funded patients.使用质量指标比较公立和私立医保患者永久性心脏起搏器植入的结果。
Intern Med J. 2015 Aug;45(8):813-20. doi: 10.1111/imj.12762.
3
Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems.永久性起搏器植入的早期并发症:双腔和单腔系统之间无差异。
Br Heart J. 1995 Jun;73(6):571-5. doi: 10.1136/hrt.73.6.571.
4
Life expectancy after implantation of a first cardiac permanent pacemaker (1995-2008): A population-based study.首次植入心脏永久起搏器后的预期寿命(1995 - 2008年):一项基于人群的研究。
Int J Cardiol. 2015;190:42-6. doi: 10.1016/j.ijcard.2015.04.099. Epub 2015 Apr 15.
5
[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].[威尼托地区透析与移植登记处:2006 - 2007年报告]
G Ital Nefrol. 2009 Nov-Dec;26 Suppl 48:S5-56.
6
Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators.与双腔起搏相比,心室起搏治疗老年患者的生活质量和临床结局。老年起搏器选择研究组。
N Engl J Med. 1998 Apr 16;338(16):1097-104. doi: 10.1056/NEJM199804163381602.
7
The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.双腔与VVI植入式心脏除颤器(DAVID)试验:原理、设计、结果、临床意义及对未来试验的启示
Card Electrophysiol Rev. 2003 Dec;7(4):468-72. doi: 10.1023/B:CEPR.0000023165.20987.b1.
8
Tricuspid regurgitation and implantable devices.三尖瓣反流与可植入装置
Pacing Clin Electrophysiol. 2015 Feb;38(2):259-66. doi: 10.1111/pace.12530. Epub 2014 Nov 7.
9
Trends in Cardiac Tamponade Among Recipients of Permanent Pacemakers in the United States: From 2008 to 2012.美国永久性心脏起搏器植入患者中心包填塞趋势:2008 年至 2012 年。
JACC Clin Electrophysiol. 2017 Jan;3(1):41-46. doi: 10.1016/j.jacep.2016.05.009. Epub 2016 Aug 3.
10
Atrio-ventricular junction ablation and pacemaker treatment: a comparison between men and women.房室交界区消融与起搏器治疗:男性与女性的比较
Scand Cardiovasc J. 2018 Jun;52(3):120-126. doi: 10.1080/14017431.2018.1446549. Epub 2018 Mar 14.

引用本文的文献

1
Patients' Needs and Preferences for Cardiac Pacemaker Implantation: A Qualitative Study on Disease and Medical Device Characteristics to Inform a Quantitative Preference Study.心脏起搏器植入患者的需求与偏好:一项关于疾病和医疗设备特征的定性研究,为定量偏好研究提供信息。
Patient. 2025 Aug 14. doi: 10.1007/s40271-025-00767-1.
2
Metabolic Status and Atrioventricular Block Risk: The Role of Physical Activity.代谢状况与房室传导阻滞风险:体力活动的作用
Rev Cardiovasc Med. 2025 May 20;26(5):37291. doi: 10.31083/RCM37291. eCollection 2025 May.
3
Ultrasound-guided versus fluoroscopy-guided axillary vein puncture for cardiac implantable electronic device implantation: a meta-analysis enrolling 1257 patients.

本文引用的文献

1
Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.瑞典植入式电子设备的使用现状:来自瑞典起搏器和植入式心脏复律除颤器注册中心的数据。
Europace. 2015 Jan;17(1):69-77. doi: 10.1093/europace/euu233. Epub 2014 Oct 21.
2
Clinical effectiveness of cardiac resynchronization therapy versus medical therapy alone among patients with heart failure: analysis of the ICD Registry and ADHERE.心力衰竭患者中,心脏再同步治疗与单纯药物治疗的临床疗效比较:ICD注册研究与ADHERE分析
Circ Heart Fail. 2014 Nov;7(6):926-34. doi: 10.1161/CIRCHEARTFAILURE.113.000838. Epub 2014 Sep 16.
3
超声引导与透视引导下心脏植入式电子装置植入时腋静脉穿刺的比较:一项纳入1257例患者的荟萃分析
J Interv Card Electrophysiol. 2024 Oct 24. doi: 10.1007/s10840-024-01932-6.
4
Echocardiographic screening for heart failure and optimization of the care pathway for individuals with pacemakers: a randomized controlled trial.超声心动图筛查心力衰竭和优化起搏器个体的护理途径:一项随机对照试验。
Nat Med. 2024 Nov;30(11):3303-3309. doi: 10.1038/s41591-024-03265-3. Epub 2024 Sep 19.
5
Utilizing Leadless Pacemakers in Extremely Elderly Patients With a Conventional Pacemaker System: A Two-Year Follow-Up Case Series Without Generator Extraction in High-Risk Scenarios.在患有传统起搏器系统的高龄患者中使用无导线起搏器:一项为期两年的随访病例系列研究,在高风险情况下未进行发生器拔除
Cureus. 2024 Aug 16;16(8):e67003. doi: 10.7759/cureus.67003. eCollection 2024 Aug.
6
Artificial Intelligence-Enabled Electrocardiography Predicts Future Pacemaker Implantation and Adverse Cardiovascular Events.人工智能心电图预测未来起搏器植入和不良心血管事件。
J Med Syst. 2024 Jul 19;48(1):67. doi: 10.1007/s10916-024-02088-6.
7
Conduction System Pacing: Hope, Challenges, and the Journey Forward.心脏传导系统起搏:希望、挑战与前行之路。
Curr Cardiol Rep. 2024 Aug;26(8):801-814. doi: 10.1007/s11886-024-02085-8. Epub 2024 Jul 8.
8
Incidence of Coronary Artery Disease After Permanent Pacemaker Implantation: A Hospital-based Study from East India.永久性起搏器植入术后冠状动脉疾病的发生率:一项来自印度东部的基于医院的研究。
J Innov Card Rhythm Manag. 2024 Jun 15;15(6):5911-5916. doi: 10.19102/icrm.2024.15065. eCollection 2024 Jun.
9
The impact of smoking on third-degree atrioventricular block outcomes: A propensity-matched analysis.吸烟对三度房室传导阻滞预后的影响:一项倾向匹配分析。
Int J Cardiol Cardiovasc Risk Prev. 2024 May 23;21:200289. doi: 10.1016/j.ijcrp.2024.200289. eCollection 2024 Jun.
10
Incidence, Risk Factors, and Outcomes of Left Atrial Enlargement in Patients Requiring Right Ventricular Pacing: A Retrospective Study of 461 Cases from 2012 to 2020.2012 年至 2020 年 461 例右心室起搏患者左心房扩大的发生率、危险因素和转归:一项回顾性研究。
Med Sci Monit. 2024 May 22;30:e944114. doi: 10.12659/MSM.944114.
Use and long-term outcomes of implantable cardioverter-defibrillators, 1990 to 2009.
1990 年至 2009 年植入式心脏复律除颤器的使用和长期疗效。
Am Heart J. 2013 May;165(5):816-22. doi: 10.1016/j.ahj.2013.02.007. Epub 2013 Mar 19.
4
An 8-year single-centre experience of cardiac resynchronisation therapy: procedural success, early and late complications, and left ventricular lead performance.8 年单中心心脏再同步治疗经验:手术成功率、早期和晚期并发症以及左心室导线性能。
Europace. 2013 May;15(5):711-7. doi: 10.1093/europace/eus401. Epub 2013 Jan 12.
5
MAMI registration report 1996-2010.1996-2010 年母婴保健注册报告。
Cardiol J. 2012;19(6):603-11. doi: 10.5603/cj.2012.0112.
6
Epidemiology of arrhythmias and conduction disorders in older adults.老年人心律失常和传导障碍的流行病学。
Clin Geriatr Med. 2012 Nov;28(4):539-53. doi: 10.1016/j.cger.2012.07.003.
7
Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker.心脏再同步治疗除颤器和心脏再同步治疗起搏器植入后第一年的 Lead 并发症、器械感染和临床结局。
Europace. 2013 Jan;15(1):71-6. doi: 10.1093/europace/eus247. Epub 2012 Aug 26.
8
The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009--a World Society of Arrhythmia's project.第11次心脏起搏与植入式心律转复除颤器全球调查:2009日历年——一项世界心律失常学会的项目
Pacing Clin Electrophysiol. 2011 Aug;34(8):1013-27. doi: 10.1111/j.1540-8159.2011.03150.x. Epub 2011 Jun 27.
9
Implantation and patient profiles for pacemakers and cardioverter-defibrillators in France (2008-2009).法国起搏器和除颤器的植入和患者概况(2008-2009 年)。
Arch Cardiovasc Dis. 2011 May;104(5):332-42. doi: 10.1016/j.acvd.2011.04.002. Epub 2011 Jun 1.
10
The Australian and New Zealand cardiac pacing and implantable cardioverter-defibrillator survey: calendar year 2009.澳大利亚和新西兰心脏起搏和植入式心脏复律除颤器调查:2009 年日历年度。
Heart Lung Circ. 2011 Feb;20(2):99-104. doi: 10.1016/j.hlc.2010.10.006. Epub 2010 Nov 13.